Trusted Resource for Clinical Trials, Protocols & Progress
Real-World Applications of Factorial Studies – Clinical Trial Design and Protocol Development “Practical Uses of Factorial Studies in the Real World” Introduction to Factorial Studies Factorial studies play a significant role in the field of clinical research and healthcare, providing a robust framework for multivariable analysis. These studies help to understand the interaction between two…
How to Handle Refusal or Withdrawal of Consent in Clinical Trials Managing Refusal or Withdrawal of Consent in Clinical Trials One of the most fundamental ethical principles in clinical research is the participant’s right to refuse or withdraw consent at any point—without penalty or loss of benefit. Handling consent refusals and withdrawals appropriately is crucial…
Read More “How to Handle Refusal or Withdrawal of Consent in Clinical Trials” »
Documenting Telehealth Interactions in EDC for Decentralized Clinical Trials How to Document Telehealth Interactions in EDC for Decentralized Trials In the evolving landscape of decentralized clinical trials (DCTs), telehealth interactions form a cornerstone of patient engagement and data collection. As these interactions often replace traditional site visits, it is critical that they are documented accurately…
Read More “Documenting Telehealth Interactions in EDC for Decentralized Clinical Trials” »
Phase 1 Trials in Rare Diseases: Study Design Constraints Designing First-in-Human Studies for Rare Disease Therapeutics Introduction Phase 1 clinical trials in rare diseases present a unique set of challenges. Unlike traditional early-phase studies that enroll healthy volunteers, trials for rare conditions often require patient participation from the outset. This is due to ethical considerations,…
Read More “Phase 1 Trials in Rare Diseases: Study Design Constraints” »
Common Red Flags to Watch for During Site Feasibility Reviews Site feasibility reviews are critical to identifying potential challenges before trial initiation. These assessments ensure that selected clinical trial sites possess the infrastructure, resources, and motivation to meet study requirements. However, sponsors and CROs often face difficulties when red flags are overlooked during this stage….
Read More “Common Red Flags During Site Feasibility Reviews in Clinical Trials” »
Managing Oversight and Accountability in Functional Service Providers (FSPs) How to Manage Oversight and Accountability in FSP Relationships As the Functional Service Provider (FSP) model gains traction in clinical research outsourcing, the importance of effective oversight and accountability becomes critical. Sponsors are responsible for ensuring that delegated clinical trial functions—whether data management, monitoring, or biostatistics—are…
Read More “Managing Oversight and Accountability in Functional Service Providers (FSPs)” »
Retention Strategies for Long-Term Follow-Up Studies in Clinical Trials Effective Retention Strategies for Long-Term Follow-Up Studies in Clinical Trials Long-term follow-up (LTFU) studies are vital to evaluating the long-term safety and efficacy of investigational treatments, particularly in oncology, gene therapy, and chronic disease research. However, retaining patients in these studies over multiple years presents unique…
Read More “Retention Strategies for Long-Term Follow-Up Studies in Clinical Trials” »
Patient Retention Strategies in Long-Term Phase 3 Studies: Keeping Participants Engaged and Compliant How to Improve Patient Retention in Long-Duration Phase 3 Clinical Trials Why Patient Retention Matters in Phase 3 Long-term Phase 3 clinical trials can span months or even years, especially in therapeutic areas like oncology, cardiovascular disease, and rare disorders. During this…
Statistical Interpretation of Combined Interventions – Clinical Trial Design and Protocol Development “Understanding the Statistical Analysis of Multiple Interventions” Introduction Statistical interpretation of combined interventions forms a crucial aspect of clinical studies, especially when it comes to the validation of the resulting data. Combined interventions are often used in clinical trials to evaluate the efficiency…
Harnessing Lessons from Site Close-Out Visits for Continuous Improvement in Clinical Trials Site Close-Out Visits (COVs) are a critical final checkpoint in a clinical trial’s lifecycle. Beyond the formalities of documentation reconciliation and investigational product (IP) accountability, these visits provide a unique opportunity to reflect, identify gaps, and initiate a cycle of continuous improvement. Learning…
Read More “Lessons Learned and Continuous Improvement After Site Close-Out Visits” »
